INSIGHT @ Work: An Interdisciplinary Study on the Ethical, Legal and Social, Implications (ELSI) of Voluntary Workplace Genomic Testing (wGT)

ELSIcon2022 • Pre-recorded Flash

  • Alyx Vogle, CGC; Betty Cohn; Rebecca Ferber; Kerry Ryan; Gregory Feero; Debra Mathews; Anya Prince; Kayte Spector-Bagdady; Kunai Sanghavi; Wendy Uhlmann; Charles Lee; J. Scott Roberts

INSIGHT @ Work: An Interdisciplinary Study on the Ethical, Legal and Social, Implications (ELSI) of Voluntary Workplace Genomic Testing (wGT)

Innovating Equitable Communication Modalities for Patient Activation and Cascade Testing for Familial Hypercholesterolemia: Cases of Ethical, Legal, and Social Complexities from a Pragmatic Trial

ELSIcon2022 • Pre-recorded Panel

  • Gemme Campbell-Salome - Geisinger
  • Amy Sturm
  • Kelly Morgan
  • Eric Tricou, MS, CGC - Geisinger, Genetic Counselor

Innovating Equitable Communication Modalities for Patient Activation and Cascade Testing for Familial Hypercholesterolemia: Cases of Ethical, Legal, and Social Complexities from a Pragmatic Trial

After 10 Years of Testing All College Athletes for Sickle Cell Trait, What Have We Learned?

All athletes playing on college sports teams governed by the National College Athletic Association (NCAA) are required to confirm their Sickle Cell Trait (SCT) status by taking a blood test or by providing prior test results. This SNAPSHOT explores the history, successes, and limitations of this mandatory SCT screening program, which was put in place to allow student athletes with SCT to safely participate in sports.